A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.
A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapy.
复制标题
DOI：
10.18632/oncotarget.5340
复制
发表时间：
2015-11-17
期刊：
影响因子：
--
通讯作者：
Ramírez de Molina A
中科院分区：
文献类型：
--
作者：
Sánchez-Martínez R;Cruz-Gil S;Gómez de Cedrón M;Álvarez-Fernández M;Vargas T;Molina S;García B;Herranz J;Moreno-Rubio J;Reglero G;Pérez-Moreno M;Feliu J;Malumbres M;Ramírez de Molina A
The alterations in carbohydrate metabolism that fuel tumor growth have been extensively studied. However, other metabolic pathways involved in malignant progression, demand further understanding. Here we describe a metabolic acyl-CoA synthetase/stearoyl-CoA desaturase ACSL/SCD network causing an epithelial-mesenchymal transition (EMT) program that promotes migration and invasion of colon cancer cells. The mesenchymal phenotype produced upon overexpression of these enzymes is reverted through reactivation of AMPK signaling. Furthermore, this network expression correlates with poorer clinical outcome of stage-II colon cancer patients. Finally, combined treatment with chemical inhibitors of ACSL/SCD selectively decreases cancer cell viability without reducing normal cells viability. Thus, ACSL/SCD network stimulates colon cancer progression through conferring increased energetic capacity and invasive and migratory properties to cancer cells, and might represent a new therapeutic opportunity for colon cancer treatment.
